Kurt Oreshack named as General Counsel for Human Longevity

Human Longevity, a genomics and cell therapy-based diagnostic and therapeutic company, revealed that Kurt Oreshack has been hired as the new General Counsel.
As quoted in the press release:

Oreshack is a Capital Markets expert, who has structured and negotiated hundreds of millions of dollars in debt and equity investments in private and public company clients.  He has guided clients through all phases of IPO preparation and execution, and public company reporting and compliance.  He has also led M&A teams in billions of dollars of transactions, representing both acquirors and acquisition targets.

Co-Founder and CEO Dr. J. Craig Venter comments:

Kurt joins our team at an exciting time, as we are working to revolutionize the practice of medicine and enable pharmaceutical companies, insurers and healthcare providers to impact and improve health.

Click here to read the full press release.